Mail

UK markets close in 5 hours 20 minutes

FTSE 100
8,385.32
-38.88(-0.46%)
FTSE 250
20,774.33
-99.00(-0.47%)
AIM
807.78
-2.16(-0.27%)
GBP/EUR
1.1694
-0.0004(-0.03%)
GBP/USD
1.2716
+0.0009(+0.07%)
Bitcoin GBP
55,855.35
+3,105.68(+5.89%)

What pension research reveals about retirement planning

As the cost of living crisis eases, what steps are you taking to build your pension?

RepliCel Life Sciences Inc. (RP.V)

TSXV - TSXV Real-time price. Currency in CAD

Add to watchlist

0.0550

0.0000

(0.00%)

At close: 03:56PM EDT

Currency in CAD

Valuation measures⁴

Market cap (intra-day)	3.58M
Enterprise value	3.58M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	7.19
Price/book (mrq)	N/A
Enterprise value/revenue	10.13
Enterprise value/EBITDA	-2.78

Trading information

Stock price history

Beta (5Y monthly)	0.77
52-week change ³	-63.33%
S&P500 52-week change ³	28.04%
52-week high ³	0.2500
52-week low ³	0.0400
50-day moving average ³	0.0554
200-day moving average ³	0.0812

Share statistics

Avg vol (3-month) ³	2.99k
Avg vol (10-day) ³	N/A
Shares outstanding ⁵	65M
Implied shares outstanding ⁶	65M
Float ⁸	23.06M
% held by insiders ¹	62.69%
% held by institutions ¹	0.00%
Shares short (30 Apr 2024) ⁴	869
Short ratio (30 Apr 2024) ⁴	N/A
Short % of float (30 Apr 2024) ⁴	0.00%
Short % of shares outstanding (30 Apr 2024) ⁴	0.00%
Shares short (prior month 28 Mar 2024) ⁴	869

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	10 Aug 2016
Ex-dividend date ⁴	N/A
Last split factor ²	1:10
Last split date ³	10 Aug 2016

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2022
Most-recent quarter (mrq)	30 Sept 2023

Profitability

Profit margin	-19.59%
Operating margin (ttm)	-368.05%

Management effectiveness

Return on assets (ttm)	-232.72%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	353.74k
Revenue per share (ttm)	0.01
Quarterly revenue growth (yoy)	0.00%
Gross profit (ttm)	N/A
EBITDA	-1.47M
Net income avi to common (ttm)	-69.29k
Diluted EPS (ttm)	-0.0200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	32.48k
Total cash per share (mrq)	0
Total debt (mrq)	811.38k
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.13
Book value per share (mrq)	-0.10

Cash flow statement

Operating cash flow (ttm)	-1.99M
Levered free cash flow (ttm)	-1.15M